The Activity and Safety of Anlotinib for Patients with Extremity Desmoid Fibromatosis: A Retrospective Study in a Single Institution

Chuanxi Zheng,* Yong Zhou,* Yitian Wang, Yi Luo, Chongqi Tu, Li Min Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China*These authors contributed equally to this workCorrespondence: Li MinDepartment of Orthopedics, West China...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zheng C, Zhou Y, Wang Y, Luo Y, Tu C, Min L
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2020-09-01
Schriftenreihe:	Drug Design, Development and Therapy
Schlagworte:	desmoid fibromatosis anlotinib tyrosine kinase inhibitor targeted therapy
Online-Zugang:	https://www.dovepress.com/the-activity-and-safety-of-anlotinib-for-patients-with-extremity-desmo-peer-reviewed-article-DDDT
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!